Almarai signs MoU with Sadan to support the Itminan Early Detection Initiative

Almarai signed a Memorandum of Understanding (MoU) with the Saudi Cancer Society (Sadan) to support the “Itminan” initiative for awareness and early detection of cancer. The agreement demonstrates Almarai’s commitment to social responsibility and community health, in line with Saudi Vision 2030 to enhance quality of life and overall well-being. The MoU was signed at Almarai’s headquarters on Monday, 15th September 2025, by Mr. Faisal Alfahadi, Executive Vice President of Communication and Corporate Affairs at Almarai, and Mr. Moqbel Mohammed Al Sarea, Chief Executive Officer of the Saudi Cancer Society, in the presence of senior representatives from both organizations.

Through this agreement, Almarai will support Sadan’s efforts to cover patient needs such as travel tickets, accommodation, transportation, and monthly financial assistance, helping ease treatment-related burdens and ensure continuity of treatment. The contribution is directed to the “Itminan” initiative, which Sadan runs as part of its early detection and health education services through specialized centers. In 2024 alone, Sadan provided more than 29,000 services to beneficiaries. By 2025, its Patients’ Housing Program had achieved a cumulative 143% growth over four years, demonstrating the society’s expanding reach and the vital role of partnerships in advancing prevention and enhancing quality of life.

"This agreement reflects Almarai’s national commitment to supporting initiatives that focus on prevention and early detection. We believe that community partnerships are central to our sustainability approach, contributing to better quality of life and supporting the realization of Saudi Vision 2030 through meaningful and lasting impact," said Mr. Faisal Alfahadi, Executive Vice President of Communication and Corporate Affairs at Almarai.

"Almarai’s support for the ‘Itminan’ initiative is an important step that enhances our ability to expand services for beneficiaries and raise awareness about the importance of early detection as a vital factor in improving treatment and recovery outcomes. We value this partnership, which reflects the integration of efforts between the private sector and charitable organizations to serve community health," said Mr. Moqbel Mohammed Al Sarea, Chief Executive Officer of the Saudi Cancer Society (Sadan).

Almarai directs its efforts towards initiatives aligned with its strategic pillars in serving the community. Each year, the company is proud to support around 400 charitable organizations that make a tangible difference. In 2024 alone, Almarai allocated more than SAR 50 million to support these organizations across the GCC countries, through programs focusing on education, health, and food. The company also invests in partnerships that ensure lasting community impact, fully aligned with Saudi Vision 2030 goals to improve quality of life and drive sustainable development.